Latest filing published 03 Feb 2015 for NOVAVAX INC, €10k.
No signal scores available.
Based on 3 purchases whose 90-day window has closed (published at least 91 days ago), the same population our ranking model reads.
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Russell P. Wilson is a declared insider at 2 companies; the most frequent names are Iomai Corp and Novavax Inc. In total, 23 filings cover trades dated from 20 August 2007 to 31 January 2015.
The open-market side counts 3 purchases for €27k alongside 12 sales for €407k. On balance, insiders were net sellers of €380k. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. Other entries cover 7 option exercises. In 2015 alone, the filings show 1 purchase and no sales.
The median purchase comes to €8,495. After 3 purchases with a full 90-day history, the hit rate stands at 33% and the median 90-day move at -1.3%. Past outcomes like these are no guarantee of what comes next.
On 3 February 2015 came the latest disclosure, an open-market purchase for €10k in Novavax Inc. Half of the filings or more reach the SEC (Form 4) feed on the day of the trade. US insiders must file a Form 4 within two business days of a trade. A sale on its own says little: insiders also sell to pay tax, fund a purchase or diversify. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
21 of 21 declarations